Anixa Historical Balance Sheet

ANIX Stock

USD 2.60 0.13 4.76%

Trend analysis of Anixa Biosciences balance sheet accounts such as Other Current Liab of 2.1 M, Total Current Liabilities of 2.4 M or Total Stockholder Equity of 29.4 M provides information on Anixa Biosciences' total assets, liabilities, and equity, which is the actual value of Anixa Biosciences to its prevalent stockholders. By breaking down trends over time using Anixa Biosciences balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Anixa Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Anixa Biosciences is a good buy for the upcoming year.

Anixa Biosciences Inventory

(39,330)

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anixa Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.

About Anixa Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Anixa Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Anixa Biosciences Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Anixa Biosciences and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Anixa currently owns. An asset can also be divided into two categories, current and non-current.

Anixa Biosciences Balance Sheet Chart

Anixa Biosciences Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Anixa Biosciences uses and utilizes its capital. It also shows what exactly a company owns and owes.

At this time, Anixa Biosciences' Property Plant Equipment is fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 35.1 M in 2024, whereas Property Plant And Equipment Net is likely to drop slightly above 132.1 K in 2024.

Total Assets Other Current Liab Total Current Liabilities Property Plant And Equipment Net Capital Lease Obligations

Add Fundamental

Total Assets

Total assets refers to the total amount of Anixa Biosciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Anixa Biosciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Anixa Biosciences balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Anixa Biosciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Capital Lease Obligations

Anixa Biosciences capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Anixa Biosciences asset purchases. For example, Anixa Biosciences can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Anixa Biosciences control over an asset for a big portion of its life. The total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee.

Most accounts from Anixa Biosciences' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Anixa Biosciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anixa Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.At this time, Anixa Biosciences' Property Plant Equipment is fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 35.1 M in 2024, whereas Property Plant And Equipment Net is likely to drop slightly above 132.1 K in 2024.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	1.7M	1.8M	2.0M	2.1M
Total Assets	30.4M	25.5M	29.4M	30.8M

Other Current Liab Total Assets

Anixa Biosciences balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Non Currrent Assets Other	Net Receivables	Accounts Payable	Non Current Liabilities Total	Common Stock Total Equity	Short Term Investments	Common Stock	Other Assets	Property Plant Equipment
Total Assets		0.81	0.39	0.98	0.43	-0.55	-0.67	0.53	-0.54	0.99	0.88	0.2	0.52	0.82	-0.29	0.43	0.99	-0.2	-0.34	-0.61	-0.52	-0.32	0.81	-0.32	-0.23	0.64
Other Current Liab	0.81		0.62	0.81	0.21	-0.15	-0.68	0.09	-0.54	0.81	0.9	0.0	0.23	0.84	-0.24	0.21	0.82	-0.17	-0.33	-0.39	-0.54	-0.13	0.91	-0.13	-0.26	0.5
Total Current Liabilities	0.39	0.62		0.28	-0.29	0.21	-0.45	-0.15	0.17	0.32	0.47	0.08	-0.03	0.52	0.47	-0.29	0.34	-0.18	-0.47	0.03	0.14	0.47	0.54	0.47	-0.44	-0.05
Total Stockholder Equity	0.98	0.81	0.28		0.51	-0.59	-0.65	0.54	-0.67	1.0	0.9	0.13	0.55	0.81	-0.46	0.51	1.0	-0.19	-0.27	-0.63	-0.67	-0.44	0.8	-0.44	-0.15	0.7
Property Plant And Equipment Net	0.43	0.21	-0.29	0.51		-0.46	0.05	0.44	-0.71	0.49	0.3	0.0	0.42	0.08	-0.61	1.0	0.48	-0.13	0.4	-0.53	-0.61	-0.51	0.26	-0.51	0.56	0.92
Net Debt	-0.55	-0.15	0.21	-0.59	-0.46		0.29	-0.98	0.4	-0.59	-0.32	0.05	-0.81	-0.25	0.41	-0.46	-0.56	0.12	0.19	0.37	0.41	0.27	0.01	0.27	0.03	-0.34
Retained Earnings	-0.67	-0.68	-0.45	-0.65	0.05	0.29		-0.28	0.36	-0.66	-0.82	0.21	-0.42	-0.92	0.12	0.05	-0.67	0.05	0.85	0.02	0.32	0.34	-0.59	0.34	0.78	-0.15
Cash	0.53	0.09	-0.15	0.54	0.44	-0.98	-0.28		-0.32	0.56	0.27	-0.02	0.82	0.23	-0.29	0.44	0.53	-0.03	-0.22	-0.32	-0.3	-0.22	-0.05	-0.22	-0.06	0.31
Non Current Assets Total	-0.54	-0.54	0.17	-0.67	-0.71	0.4	0.36	-0.32		-0.62	-0.66	0.33	-0.46	-0.47	0.88	-0.71	-0.62	-0.02	-0.09	0.46	0.94	0.74	-0.5	0.74	-0.23	-0.77
Cash And Short Term Investments	0.99	0.81	0.32	1.0	0.49	-0.59	-0.66	0.56	-0.62		0.89	0.14	0.56	0.81	-0.38	0.49	1.0	-0.18	-0.31	-0.62	-0.6	-0.39	0.8	-0.39	-0.19	0.68
Common Stock Shares Outstanding	0.88	0.9	0.47	0.9	0.3	-0.32	-0.82	0.27	-0.66	0.89		-0.12	0.46	0.95	-0.38	0.3	0.9	-0.22	-0.49	-0.44	-0.63	-0.44	0.87	-0.44	-0.37	0.58
Inventory	0.2	0.0	0.08	0.13	0.0	0.05	0.21	-0.02	0.33	0.14	-0.12		-0.37	-0.09	0.28	0.0	0.15	0.11	0.3	-0.12	0.25	0.22	0.2	0.22	0.11	0.05
Other Current Assets	0.52	0.23	-0.03	0.55	0.42	-0.81	-0.42	0.82	-0.46	0.56	0.46	-0.37		0.39	-0.36	0.42	0.54	-0.18	-0.33	-0.36	-0.42	-0.29	0.07	-0.29	-0.13	0.39
Other Stockholder Equity	0.82	0.84	0.52	0.81	0.08	-0.25	-0.92	0.23	-0.47	0.81	0.95	-0.09	0.39		-0.2	0.08	0.82	-0.11	-0.68	-0.25	-0.44	-0.38	0.81	-0.38	-0.62	0.38
Total Liab	-0.29	-0.24	0.47	-0.46	-0.61	0.41	0.12	-0.29	0.88	-0.38	-0.38	0.28	-0.36	-0.2		-0.61	-0.38	0.02	-0.25	0.35	0.93	0.76	-0.22	0.76	-0.35	-0.59
Property Plant And Equipment Gross	0.43	0.21	-0.29	0.51	1.0	-0.46	0.05	0.44	-0.71	0.49	0.3	0.0	0.42	0.08	-0.61		0.48	-0.13	0.4	-0.53	-0.61	-0.51	0.26	-0.51	0.56	0.92
Total Current Assets	0.99	0.82	0.34	1.0	0.48	-0.56	-0.67	0.53	-0.62	1.0	0.9	0.15	0.54	0.82	-0.38	0.48		-0.18	-0.3	-0.62	-0.6	-0.39	0.82	-0.39	-0.19	0.68
Non Currrent Assets Other	-0.2	-0.17	-0.18	-0.19	-0.13	0.12	0.05	-0.03	-0.02	-0.18	-0.22	0.11	-0.18	-0.11	0.02	-0.13	-0.18		0.08	0.45	0.1	-0.11	-0.18	-0.11	-0.06	-0.18
Net Receivables	-0.34	-0.33	-0.47	-0.27	0.4	0.19	0.85	-0.22	-0.09	-0.31	-0.49	0.3	-0.33	-0.68	-0.25	0.4	-0.3	0.08		-0.28	-0.12	0.04	-0.2	0.04	0.95	0.26
Accounts Payable	-0.61	-0.39	0.03	-0.63	-0.53	0.37	0.02	-0.32	0.46	-0.62	-0.44	-0.12	-0.36	-0.25	0.35	-0.53	-0.62	0.45	-0.28		0.45	0.26	-0.52	0.26	-0.42	-0.63
Non Current Liabilities Total	-0.52	-0.54	0.14	-0.67	-0.61	0.41	0.32	-0.3	0.94	-0.6	-0.63	0.25	-0.42	-0.44	0.93	-0.61	-0.6	0.1	-0.12	0.45		0.66	-0.49	0.66	-0.25	-0.68
Common Stock Total Equity	-0.32	-0.13	0.47	-0.44	-0.51	0.27	0.34	-0.22	0.74	-0.39	-0.44	0.22	-0.29	-0.38	0.76	-0.51	-0.39	-0.11	0.04	0.26	0.66		-0.29	1.0	-0.03	-0.55
Short Term Investments	0.81	0.91	0.54	0.8	0.26	0.01	-0.59	-0.05	-0.5	0.8	0.87	0.2	0.07	0.81	-0.22	0.26	0.82	-0.18	-0.2	-0.52	-0.49	-0.29		-0.29	-0.17	0.59
Common Stock	-0.32	-0.13	0.47	-0.44	-0.51	0.27	0.34	-0.22	0.74	-0.39	-0.44	0.22	-0.29	-0.38	0.76	-0.51	-0.39	-0.11	0.04	0.26	0.66	1.0	-0.29		-0.03	-0.55
Other Assets	-0.23	-0.26	-0.44	-0.15	0.56	0.03	0.78	-0.06	-0.23	-0.19	-0.37	0.11	-0.13	-0.62	-0.35	0.56	-0.19	-0.06	0.95	-0.42	-0.25	-0.03	-0.17	-0.03		0.4
Property Plant Equipment	0.64	0.5	-0.05	0.7	0.92	-0.34	-0.15	0.31	-0.77	0.68	0.58	0.05	0.39	0.38	-0.59	0.92	0.68	-0.18	0.26	-0.63	-0.68	-0.55	0.59	-0.55	0.4

Click cells to compare fundamentals

Anixa Biosciences Account Relationship Matchups

Anixa Biosciences balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	9.5M	36.3M	30.4M	25.5M	29.4M	30.8M
Other Current Liab	901.0K	1.1M	1.7M	1.8M	2.0M	2.1M
Total Current Liabilities	1.2M	1.3M	2.0M	2.0M	2.3M	2.4M
Total Stockholder Equity	8.8M	35.4M	29.0M	24.3M	28.0M	29.4M
Property Plant And Equipment Net	54.3K	254.0K	212K	166K	149.4K	132.1K
Net Debt	(6.4M)	(28.9M)	(12.1M)	(740K)	(666K)	(699.3K)
Retained Earnings	(191.8M)	(204.8M)	(218.4M)	(228.2M)	(205.4M)	(195.1M)
Cash	6.4M	29.1M	12.4M	915K	1.1M	999.6K
Non Current Assets Total	84.3K	254.0K	212K	166K	190.9K	181.4K
Cash And Short Term Investments	9.1M	35.7M	29.7M	23.8M	27.4M	28.8M
Common Stock Shares Outstanding	22.2M	28.6M	30.4M	31.0M	35.6M	37.4M
Liabilities And Stockholders Equity	9.5M	36.3M	30.4M	25.5M	29.4M	30.8M
Inventory	1.0	(2.4M)	(2.6M)	(46K)	(41.4K)	(39.3K)
Other Current Assets	2.9M	6.9M	513K	1.2M	1.4M	897.9K
Other Stockholder Equity	200.4M	239.9M	247.1M	252.2M	290.1M	304.6M
Total Liab	1.2M	1.5M	2.2M	2.2M	2.5M	2.2M
Property Plant And Equipment Gross	54.3K	254.0K	212K	166K	149.4K	132.1K
Total Current Assets	9.4M	36.0M	30.2M	25.4M	29.2M	30.6M
Non Currrent Assets Other	910.2K	(200.6K)	30K	(212K)	(243.8K)	(231.6K)
Net Receivables	66.5K	2.2K	46K	270K	243K	231.6K
Accounts Payable	232.4K	136.2K	265K	206K	185.4K	176.1K
Non Current Liabilities Total	287.6K	220.1K	175K	123K	141.5K	134.4K
Common Stock Total Equity	189.1K	203.3K	242.5K	309K	278.1K	264.2K
Short Term Investments	2.6M	6.6M	17.3M	22.9M	26.4M	27.7M
Common Stock	242.5K	300.5K	309K	311K	279.9K	265.9K
Property Plant Equipment	200.6K	54.3K	254.0K	212K	243.8K	256.0K
Net Tangible Assets	5.2M	8.8M	35.4M	29.0M	33.4M	35.1M
Noncontrolling Interest In Consolidated Entity	(251.4K)	(423.0K)	(497.0K)	(847K)	(762.3K)	(724.2K)
Retained Earnings Total Equity	(170.2M)	(181.8M)	(191.8M)	(218.4M)	(196.5M)	(206.4M)
Capital Surpluse	175.4M	186.8M	200.4M	247.1M	284.2M	181.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

GOOG	Alphabet Inc Class C
BAC	Bank of America
DD	Dupont De Nemours

When determining whether Anixa Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Anixa Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Anixa Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Anixa Biosciences Stock:

How To Invest In Anixa

Details

Is Anixa Stock a good investment?

Details

What is Anixa Biosciences' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.

You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Anixa Stock analysis

When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.

	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Transaction History View history of all your transactions and understand their impact on performance
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Volatility Analysis Get historical volatility and risk analysis based on latest market data

Is Anixa Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anixa Biosciences. If investors know Anixa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anixa Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.34)

Revenue Per Share

0.007

Return On Assets

(0.28)

Return On Equity

(0.43)

The market value of Anixa Biosciences is measured differently than its book value, which is the value of Anixa that is recorded on the company's balance sheet. Investors also form their own opinion of Anixa Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Anixa Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anixa Biosciences' market value can be influenced by many factors that don't directly affect Anixa Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Anixa Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anixa Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anixa Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Anixa Historical Balance Sheet

Anixa Biosciences Inventory

(39,330)

About Anixa Balance Sheet Analysis

Anixa Biosciences Balance Sheet Chart

Total Assets

Total Current Liabilities

Property Plant And Equipment Net

Capital Lease Obligations

Anixa Biosciences balance sheet Correlations

Anixa Biosciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Anixa Biosciences balance sheet Accounts

Also Currently Popular

Complementary Tools for Anixa Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Total Stockholder Equity
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock	+ 1.0	Common Stock Total Equity
Cash And Short Term Investments	+ 0.99	Total Assets

Cash	- 0.98	Net Debt
Other Stockholder Equity	- 0.92	Retained Earnings
Common Stock Shares Outstanding	- 0.82	Retained Earnings
Other Current Assets	- 0.81	Net Debt
Property Plant Equipment	- 0.77	Non Current Assets Total
Property Plant And Equipment Gross	- 0.71	Non Current Assets Total